Skip to main content
$63.25 -$0.26 (-0.4%)

04:00 PM EST on 12/08/23

AstraZeneca plc (ADR) (NASDAQ:AZN)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

Current Price $63.25 Mkt Cap $196.1B
Open $63.66 P/E Ratio 33.24
Prev. Close $63.25 Div. (Yield) $1.45 (1.4%)
Daily Range $63.03 - $63.69 Volume 4,586,856
52-Wk Range $61.73 - $76.56 Avg. Daily Vol. 5,520,025

Caps

How do you think NASDAQ:AZN will perform against the market?

Add Stock to CAPS Watchlist

All Players

745 Outperform
38 Underperform
 

All-Star Players

135 Outperform
6 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:AZN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFkodyk123 (32.14)
Submitted July 20, 2021

AstraZeneca is primed to expand its presence within the huge and growing orphan drug market, expand its market share in China's oncology market via its new indication for Imfinzi, and the stock is trading at a discount to fair value.

KingPortu (95.97)
Submitted October 29, 2007

I like the MedImmune acquisition but their balance sheet looks like crap- 5billion in cash vs 15billion in debt, plus negative earnings and revenue. Think it will take some time before the MedImmune acquisition starts to pay off

Recent Community Commentary

Read the most recent pitches from players about AZN.

Recs

1
Member Avatar TMFkodyk123 (32.14) Submitted: 7/19/2021 8:32:50 PM : Outperform Start Price: $53.57 NASDAQ:AZN Score: +10.06

AstraZeneca is primed to expand its presence within the huge and growing orphan drug market, expand its market share in China's oncology market via its new indication for Imfinzi, and the stock is trading at a discount to fair value.

Recs

1
Member Avatar RCi (46.88) Submitted: 1/10/2021 2:53:36 PM : Outperform Start Price: $47.55 NASDAQ:AZN Score: +11.61

Revenue growth and Profit margins.

Recs

1
Member Avatar XMFZhiyuanSun (< 20) Submitted: 9/13/2020 8:41:06 PM : Outperform Start Price: $47.55 NASDAQ:AZN Score: +12.08

Promising COVID-19 vaccine in development by EoY.

Leaderboard

Find the members with the highest scoring picks in AZN.

Score Leader

timjake

timjake (25.98) Score: +290.26

The Score Leader is the player with the highest score across all their picks in AZN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
timjake 25.98 3/17/2008 Outperform NS $9.46 +569.18% +278.92% +290.26 1 Comment
equalfuture 23.09 3/18/2008 Outperform 1Y $9.76 +548.65% +267.19% +281.47 1 Comment
snickers4niki 77.55 3/28/2008 Outperform NS $9.91 +538.76% +258.84% +279.92 0 Comment
oferm 39.18 3/19/2008 Outperform 3W $9.94 +536.53% +257.53% +278.99 0 Comment
IMakeItRain 90.35 3/14/2008 Outperform 3Y $9.98 +534.27% +261.22% +273.06 0 Comment
Ramhorn < 20 3/14/2008 Outperform NS $9.98 +534.27% +261.22% +273.06 0 Comment
gallo19 75.81 3/14/2008 Outperform NS $9.86 +542.25% +269.88% +272.37 0 Comment
b400 99.54 3/5/2008 Outperform 5Y $10.05 +529.86% +257.58% +272.28 0 Comment
floridabull33 89.74 3/27/2008 Outperform 3M $10.07 +528.67% +257.94% +270.74 1 Comment
EpicAhab 42.95 2/12/2008 Outperform 5Y $10.16 +523.16% +255.50% +267.67 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for AZN.